Статті в журналах з теми "GBM Patients"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "GBM Patients".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Connelly, Jennifer, Kathleen Schmainda, Mona Al-Gizawiy, Fernando Santos-Pinhero, and Christopher Chitambar. "TIPS-03 A PHASE 1 STUDY OF GALLIUM MALTOLATE (GAM) IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)." Neuro-Oncology Advances 5, Supplement_3 (August 1, 2023): iii34. http://dx.doi.org/10.1093/noajnl/vdad070.134.
Повний текст джерелаWu, Mengwan, Ying Shi, Luyi Zhu, Luoyi Chen, Xinchen Zhao, and Chuan Xu. "Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword." Life 12, no. 8 (August 12, 2022): 1225. http://dx.doi.org/10.3390/life12081225.
Повний текст джерелаBergallo, Massimiliano, Cristina Costa, Stefano Gambarino, Alessandra Tornicelli, Sara Astegiano, Maria Elena Terlizzi, Paolo Solidoro, and Rossana Cavallo. "Human cytomegalovirus glycoprotein B genotyping from bronchoalveolar lavage specimens." Canadian Journal of Microbiology 57, no. 4 (April 2011): 273–77. http://dx.doi.org/10.1139/w11-014.
Повний текст джерелаNelson, James S. "Alzheimer Pathology in Elderly Patients With Glioblastoma Multiforme." Archives of Pathology & Laboratory Medicine 126, no. 12 (December 1, 2002): 1515–17. http://dx.doi.org/10.5858/2002-126-1515-apiepw.
Повний текст джерелаBotturi, M., L. Fariselli, I. Milanesi, D. Asnaghi, S. Bracelli, G. Broggi, and D. Zanni. "GBM: A review of 118 patients." European Journal of Cancer 29 (January 1993): S193. http://dx.doi.org/10.1016/0959-8049(93)91700-u.
Повний текст джерелаNakamura, Masaya, Osahiko Tsuji, Kanehiro Fujiyoshi, Kota Watanabe, Takashi Tsuji, Ken Ishii, Morio Matsumoto, Yoshiaki Toyama, and Kazuhiro Chiba. "Cordotomy for patients with thoracic malignant astrocytoma." Journal of Neurosurgery: Spine 13, no. 4 (October 2010): 418–23. http://dx.doi.org/10.3171/2010.4.spine09901.
Повний текст джерелаLarionova, T. D., T. F. Kovalenko, M. I. Shakhparonov, and M. S. Pavlyukov. "The Prognostic Significance of Spliceosomal Proteins for Patients with Glioblastoma." Doklady Biochemistry and Biophysics 503, no. 1 (April 2022): 71–75. http://dx.doi.org/10.1134/s1607672922020090.
Повний текст джерелаTakeuchi, Yasuo, Emiko Takeuchi, and Kouju Kamata. "A Possible Clue for the Production of Anti-Glomerular Basement Membrane Antibody Associated with Ureteral Obstruction and Hydronephrosis." Case Reports in Nephrology and Dialysis 5, no. 1 (March 31, 2015): 87–95. http://dx.doi.org/10.1159/000381396.
Повний текст джерелаChabot, Peter, Dominique Fontaine, Carmen del Genio, Yujia Shentu, and Arti Gaur. "BIOM-14. SYSTEMIC BIOMARKERS OF TUMOR BURDEN IN GLIOBLASTOMA PATIENTS." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii7. http://dx.doi.org/10.1093/neuonc/noac209.024.
Повний текст джерелаBacha, Jeffrey A., Anne Steino, Richard Stephen Schwartz, John Langlands, Sarath Kanekal, Lorena Lopez, Barbara Jane O'Brien, Zhongping Chen, Marta Penas-Prado, and Dennis Brown. "Clinical trials of VAL-083 in patients with chemo-resistant glioblastoma." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): TPS2082. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps2082.
Повний текст джерелаHorta, Erika, Tobias Walbert, and James Snyder. "EPID-11. OCCURRENCE OF SYSTEMIC CANCER IN PATIENTS WITH GLIOBLASTOMA: POPULATION CHARACTERIZATION AND COMPLICATIONS." Neuro-Oncology 21, Supplement_6 (November 2019): vi76. http://dx.doi.org/10.1093/neuonc/noz175.311.
Повний текст джерелаLynch, David, Branka Powter, Joseph William Po, Adam Cooper, Celine Garrett, Eng-Siew Koh, Mark Sheridan, et al. "Isolation of Circulating Tumor Cells from Glioblastoma Patients by Direct Immunomagnetic Targeting." Applied Sciences 10, no. 9 (May 11, 2020): 3338. http://dx.doi.org/10.3390/app10093338.
Повний текст джерелаShi, Zhong-Fang, Guan-Zhang Li, You Zhai, Chang-Qing Pan, Di Wang, Ming-Chen Yu, Chi Liu, Wei Zhang та Xiao-Guang Yu. "EGFRvIII Promotes the Proneural–Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis". Genes 14, № 3 (4 березня 2023): 651. http://dx.doi.org/10.3390/genes14030651.
Повний текст джерелаMunoz, Yamhilette Licon, Rachel B. Sidebottom, Frank J. Martinez, Samantha Varela, Christian A. Bowers, and Sara G. M. Piccirillo. "Abstract 5802: The impact of tumor-treating fields on cancer stem-like cells isolated from the sub-ventricular zone of glioblastoma patients." Cancer Research 83, no. 7_Supplement (April 4, 2023): 5802. http://dx.doi.org/10.1158/1538-7445.am2023-5802.
Повний текст джерелаDamestani, Yasaman, Minesh P. Mehta, Howard Colman, Kevin A. Camphausen, Michael Weller, Evanthia Galanis, Martin J. Van Den Bent, et al. "Digital measurement of functional status of patients with glioblastoma." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 2016. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.2016.
Повний текст джерелаAlijani, Babak, Hamid Saeidi Saedi, Hadi Hajizadeh Fallah, Ehsan Kazemnejad Leili, Adel Kiumarsi, and Sasan Andalib. "Evaluation of effect of epidermal growth factor receptor and vascular endothelial growth factor overexpression in survival of patients with glioblastoma multiforme." Romanian Journal of Neurology 20, no. 1 (March 31, 2021): 66–71. http://dx.doi.org/10.37897/rjn.2021.1.9.
Повний текст джерелаGmurczyk, Aleksandra, Shubhada N. Ahya, Robert Goldschmidt, George Kim, L. Tammy Ho, and Kevin Nash. "A Case of Simultaneous, Biopsy-Proven, Classic, ANCA-Positive Wegener's Granulomatosis and Anti-GBM Disease, but without Detectible Circulating Anti-GBM Antibodies." Scientific World JOURNAL 10 (2010): 1078–83. http://dx.doi.org/10.1100/tsw.2010.107.
Повний текст джерелаSloan, Anthony, Theresa Elder, Ansh Desai, Anna Wu, Serah Choi, and Andrew Sloan. "NCMP-06. VENOUS THROMBOEMBOLISM INCIDENCE AND THE IMPACT OF PRE-DISEASED ANTICOAGULATION THERAPY IN GLIOBLASTOMA PATIENTS." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii192. http://dx.doi.org/10.1093/neuonc/noac209.734.
Повний текст джерелаTroike, Katie M., Arlet M. Acanda de la Rocha, Tyler J. Alban, Matthew M. Grabowski, Balint Otvos, Gino Cioffi, Kristin A. Waite, et al. "The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients." Cancers 13, no. 18 (September 8, 2021): 4525. http://dx.doi.org/10.3390/cancers13184525.
Повний текст джерелаGiamas, Georgios, Chiara Cilibrasi, Thomas Simon, Nicolas Stewart, Giles Critchley, and Murat Eravci. "BIOM-06. IDENTIFICATION OF AN INFLAMMATORY BIOMARKER SIGNATURE IN PLASMA-DERIVED EXTRACELLULAR VESICLES OF GLIOBLASTOMA PATIENTS." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii5. http://dx.doi.org/10.1093/neuonc/noac209.016.
Повний текст джерелаCurtin, Lee, Paula Whitmire, Cassandra Rickertsen, Peter D. Canoll, Maciej Mrugala, Kristin Swanson, and Leland Hu. "RARE-09. CYSTIC GLIOBLASTOMA PRESENTATION AS A BENEFICIAL PROGNOSTIC INDICATOR FOR OVERALL SURVIVAL." Neuro-Oncology 21, Supplement_6 (November 2019): vi223. http://dx.doi.org/10.1093/neuonc/noz175.932.
Повний текст джерелаGareev, I. F., O. A. Beylerli, Sh Zhao, G. Yang, J. Sun, A. T. Beilerli, and Sh M. Safin. "Extraction of Exosomes from Glioblastoma Multiforme Patients’ Blood Plasma." Creative surgery and oncology 9, no. 3 (November 20, 2019): 234–38. http://dx.doi.org/10.24060/2076-3093-2019-9-3-234-238.
Повний текст джерелаWu, Zhe Bao, Chao Qiu, An Li Zhang, Lin Cai, Shao Jian Lin, Yu Yao, Qi Sheng Tang, et al. "Glioma-Associated Antigen HEATR1 Induces Functional Cytotoxic T Lymphocytes in Patients with Glioma." Journal of Immunology Research 2014 (2014): 1–12. http://dx.doi.org/10.1155/2014/131494.
Повний текст джерелаSaadeh, Fadi S., Rami Z. Morsi, Abdallah El-Kurdi, Georges Nemer, Rami Mahfouz, Maya Charafeddine, Jessica Khoury, Marwan W. Najjar, Pierre Khoueiry, and Hazem I. Assi. "Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population." PLOS ONE 15, no. 11 (November 25, 2020): e0242793. http://dx.doi.org/10.1371/journal.pone.0242793.
Повний текст джерелаVauleon, Elodie, Tony Avril, Brigitte Collet, Jean Mosser, and Véronique Quillien. "Overview of Cellular Immunotherapy for Patients with Glioblastoma." Clinical and Developmental Immunology 2010 (2010): 1–18. http://dx.doi.org/10.1155/2010/689171.
Повний текст джерелаShah, Farah, and Zhi Sheng. "Using PIK3CB and connexin-43 inhibition to sensitize pediatric glioblastoma cells to temozolomide." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e13572-e13572. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e13572.
Повний текст джерелаMontemurro, Nicola, Paolo Perrini, and Biagio Rapone. "Clinical Risk and Overall Survival in Patients with Diabetes Mellitus, Hyperglycemia and Glioblastoma Multiforme. A Review of the Current Literature." International Journal of Environmental Research and Public Health 17, no. 22 (November 17, 2020): 8501. http://dx.doi.org/10.3390/ijerph17228501.
Повний текст джерелаRichard, Seidu A. "Explicating the Pivotal Pathogenic, Diagnostic, and Therapeutic Biomarker Potentials of Myeloid-Derived Suppressor Cells in Glioblastoma." Disease Markers 2020 (November 4, 2020): 1–13. http://dx.doi.org/10.1155/2020/8844313.
Повний текст джерелаZhou, Chengmao, Ying Wang, Mu-Huo Ji, Jianhua Tong, Jian-Jun Yang, and Hongping Xia. "Predicting Peritoneal Metastasis of Gastric Cancer Patients Based on Machine Learning." Cancer Control 27, no. 1 (January 1, 2020): 107327482096890. http://dx.doi.org/10.1177/1073274820968900.
Повний текст джерелаLi, Zhiyong, Yinghui Jin, Qingping Zou, Xiaofeng Shi, Kaishu Li, Qun He, Zhiying Lin, et al. "Integrated genomic and transcriptomic analysis identified KRT18 mutation and MTAP loss as key genetic alterations related to the prognosis of astrocytoma and glioblastoma." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e14039-e14039. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e14039.
Повний текст джерелаCilibrasi, Chiara, Thomas Simon, Marian Vintu, Christos Tolias, Mark Samuels, Nektarios Mazarakis, Murat Eravci, Nicholas Stewart, Giles Critchley, and Giorgios Giamas. "Identification of an Inflammatory Biomarker Signature in Plasma-Derived Extracellular Vesicles of Glioblastoma Patients." Neuro-Oncology 24, Supplement_4 (October 1, 2022): iv6—iv7. http://dx.doi.org/10.1093/neuonc/noac200.027.
Повний текст джерелаSantoni, Giorgio, Federica Maggi, Consuelo Amantini, Antonietta Arcella, Oliviero Marinelli, Massimo Nabissi, Matteo Santoni, and Maria Beatrice Morelli. "Coexpression of TRPML1 and TRPML2 Mucolipin Channels Affects the Survival of Glioblastoma Patients." International Journal of Molecular Sciences 23, no. 14 (July 13, 2022): 7741. http://dx.doi.org/10.3390/ijms23147741.
Повний текст джерелаWelling, Leonardo, José Carlos Lynch, Celestino Pereira, Ricardo Andrade, Fabiana Polycarpo Hidalgo, Alessandra G. L. Pereira, and Claúdia Escoteguy. "Prognostic factors in glioblastoma multiforme." Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 29, no. 04 (December 2010): 121–25. http://dx.doi.org/10.1055/s-0038-1625613.
Повний текст джерелаXia, Xiangping, Fang Cao, Xiaolu Yuan, Qiang Zhang, Wei Chen, Yunhu Yu, Hua Xiao, Chong Han, and Shengtao Yao. "Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme." PeerJ 7 (November 19, 2019): e7974. http://dx.doi.org/10.7717/peerj.7974.
Повний текст джерелаDeng, Xinqing, Jian Ren, Zhongsheng Bi, and Zhenghao Fu. "Positive Expression of Retinol-Binding Protein 4 Is Related to the Malignant Clinical Features Leading to Poor Prognosis of Glioblastoma." Genetics Research 2022 (December 26, 2022): 1–10. http://dx.doi.org/10.1155/2022/5435523.
Повний текст джерелаHuang, Bin, Ju Yang, Kongcheng Wang, Weitao Chen, Hongbin Ni, and Jing Yan. "NF1 may serve as a novel genetic biomarker of response to treatment and prognosis in glioblastoma (GBM)." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e14539-e14539. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e14539.
Повний текст джерелаBushara, Omar, Alexander Guzner, Kirsten Burdett, Patrick Murday, Matias Pollevick, Denise Scholtens, and Priya Kumthekar. "IMMU-44. PRE-DIAGNOSTIC EOSINOPHIL LEVEL AND GLIOBLASTOMA DEVELOPMENT IN PATIENTS WITH AND WITHOUT ATOPIC DISEASE." Neuro-Oncology 22, Supplement_2 (November 2020): ii114. http://dx.doi.org/10.1093/neuonc/noaa215.474.
Повний текст джерелаSapirstein, E., Y. Laviv, A. Kanner, S. Berkowitch, S. Fichman, A. Benouaich -Amiel, S. Yust-Katz, and T. Siegal. "P12.01.B Systemic metabolic features associated with significant insulin resistance in diabetes mellitus type 2 patients are related to the presence of gemistocytes in glioblastoma." Neuro-Oncology 24, Supplement_2 (September 1, 2022): ii76—ii77. http://dx.doi.org/10.1093/neuonc/noac174.266.
Повний текст джерелаPająk, Beata. "Looking for the Holy Grail—Drug Candidates for Glioblastoma Multiforme Chemotherapy." Biomedicines 10, no. 5 (April 26, 2022): 1001. http://dx.doi.org/10.3390/biomedicines10051001.
Повний текст джерелаPająk, Beata. "Looking for the Holy Grail—Drug Candidates for Glioblastoma Multiforme Chemotherapy." Biomedicines 10, no. 5 (April 26, 2022): 1001. http://dx.doi.org/10.3390/biomedicines10051001.
Повний текст джерелаLiang, Dandan, Shaoshan Liang, Feng Xu, Mingchao Zhang, Xiaomei Li, Yiyao Tu, Zhihong Liu, and Caihong Zeng. "Clinicopathological features and outcome of antibody-negative anti-glomerular basement membrane disease." Journal of Clinical Pathology 72, no. 1 (October 12, 2018): 31–37. http://dx.doi.org/10.1136/jclinpath-2018-205278.
Повний текст джерелаChahal, Manik, Brian Thiessen, and Caroline Mariano. "Treatment of Older Adult Patients with Glioblastoma: Moving towards the Inclusion of a Comprehensive Geriatric Assessment for Guiding Management." Current Oncology 29, no. 1 (January 14, 2022): 360–76. http://dx.doi.org/10.3390/curroncol29010032.
Повний текст джерелаPellerino, Alessia, Francesco Bruno, Edoardo Pronello, Francesca Mo, Federica Franchino, Roberta Rudà, and Riccardo Soffietti. "NCOG-19. PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH GLIOBLASTOMA: A RETROSPECTIVE INSTITUTIONAL SERIES OF 160 PATIENTS." Neuro-Oncology 23, Supplement_6 (November 2, 2021): vi156. http://dx.doi.org/10.1093/neuonc/noab196.610.
Повний текст джерелаLi, Qiao, Weijie Sun, Yi Lu, Didi Guo, Tiantian Han, Guanghua Lu, Xiaomin Li, Ran Ding, and Fanfeng Bu. "The analysis of EGFR variants in Chinese adult glioblastoma patients." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e14020-e14020. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e14020.
Повний текст джерелаFrandsen, Simone, Helle Broholm, Vibeke A. Larsen, Kirsten Grunnet, Søren Møller, Hans Skovgaard Poulsen, and Signe Regner Michaelsen. "RARE-21. CLINICAL CHARACTERISTICS OF GLIOSARCOMA AND OUTCOME FROM STANDARDIZED TREATMENT RELATIVE TO CONVENTIONAL GLIOBLASTOMA." Neuro-Oncology 21, Supplement_6 (November 2019): vi225—vi226. http://dx.doi.org/10.1093/neuonc/noz175.944.
Повний текст джерелаOtvos, Balint, Matthew Grabowski, Tyler Alban, Joshua Golubovsky, Chase Neumann, Anja Rabjlenovic, Defne Bayik, et al. "GENE-26. HOST GENETIC VARIATIONS IN MACROPHAGE MIGRATION INHIBITOR FACTOR CONFER WORSE PROGNOSIS IN GLIOBLASTOMA." Neuro-Oncology 21, Supplement_6 (November 2019): vi103. http://dx.doi.org/10.1093/neuonc/noz175.428.
Повний текст джерелаKim, Jung-Young, Jennifer G. Jackman, Sarah Woodring, Frances McSherry, James E. Herndon, Annick Desjardins, Henry S. Friedman, and Katherine B. Peters. "Second primary cancers in long-term survivors of glioblastoma." Neuro-Oncology Practice 6, no. 5 (February 4, 2019): 386–91. http://dx.doi.org/10.1093/nop/npz001.
Повний текст джерелаZhai, Lijie, April Bell, Jun Qian, Erik Ladomersky, Kristen Lauing, and Derek Wainwright. "IMMU-22. TARGETING NON-CANONICAL FUNCTION OF IDO1 IN GLIOBLASTOMA IMMUNOTHERAPY." Neuro-Oncology 21, Supplement_6 (November 2019): vi123. http://dx.doi.org/10.1093/neuonc/noz175.515.
Повний текст джерелаLoussouarn, Delphine, Lisa Oliver, Celine Salaud, Edouard Samarut, Raphaël Bourgade, Christophe Béroud, Emilie Morenton, Dominique Heymann, and Francois M. Vallette. "Spatial Distribution of Immune Cells in Primary and Recurrent Glioblastoma: A Small Case Study." Cancers 15, no. 12 (June 20, 2023): 3256. http://dx.doi.org/10.3390/cancers15123256.
Повний текст джерелаO'Brien, B. J., J. A. Bacha, D. M. Brown, A. Steino, R. Schwartz, S. Kanekal, L. M. Lopez, and M. Penas-Prado. "PC3 - 155 Phase II Study of Dianhydrogalactitol in Patients with MGMT-Unmethylated, Bevacizumab-Naïve Recurrent Glioblastoma." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 43, S4 (October 2016): S18. http://dx.doi.org/10.1017/cjn.2016.382.
Повний текст джерела